Veradermics Raises $256M in IPO to Advance Hair Loss Treatments
Veradermics just made a big splash in the biotech world. We’re talking about a $256 million initial public offering (IPO) that positions this company at the forefront of hair loss science. The stock began trading above its expected range, showing strong investor confidence in a business built to tackle one of the most widespread dermatology…